Biogen Inc. (BIIB)

Nasdaq · Healthcare · Drug Manufacturers - General
$249.59+1.00%As of 2026-11-22 · USD
Last session low $248.04Last session high $253.00
52-week low $160.3652-week high $261.00
Market cap
$36.89B
Sector
Healthcare
P/E (TTM)
108.0x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)54.5In the neutral range (30 to 70)
MACD (12, 26, 9)3.66Below its signal line (4.92); histogram -1.26
Bollinger %B (20, 2)41%Inside the bands (244.59 to 256.75)
SMA 20250.67Price is 0.4% below
SMA 50236.84Price is 5.4% above
SMA 200206.85Price is 20.7% above
ATR (20)2.88% of priceAverage true range per day
52-week position89%In the upper part of the 160.36 to 261.00 range

About Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Latest fiscal yearEnded 2025-12-31: revenue of $9.89B and an operating margin of 25.0%.

More in Drug Manufacturers - General